Moreover, preoperative use of β-adrenergic blockers can lead to increased insulin production from pancreatic cells and to impair liver gluconeogenesis and the glucagon secretion mechanism, subsequently contributing to the development of hypoglycemia [33]. This evidence concerns the gene INS and Hypoglycemia.